• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. Alt-proteins: A promising future
• 3. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 4. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 5. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480

Chemical Profile of 4-(4-Bromophenoxy)phenol (CAS No. 13320-48-4)

4-(4-Bromophenoxy)phenol, identified by its Chemical Abstracts Service (CAS) number 13320-48-4, is a significant compound in the realm of organic chemistry and pharmaceutical research. This phenolic derivative, featuring a brominated aromatic ring and a phenoxy substituent, has garnered attention due to its versatile structural properties and potential applications in medicinal chemistry. The presence of both bromine and hydroxyl functional groups makes it a compound of interest for synthesizing various bioactive molecules.

The structural motif of 4-(4-Bromophenoxy)phenol positions it as a valuable intermediate in the synthesis of more complex molecules. Its aromatic system, coupled with the electron-withdrawing nature of the bromine atom, influences its reactivity in different chemical transformations. This compound has been explored in the development of novel pharmacophores, particularly in the context of antimicrobial and anti-inflammatory agents. The phenoxy group introduces a polar characteristic, enhancing solubility in polar solvents, which is often crucial for drug formulation and delivery.

Recent advancements in pharmaceutical research have highlighted the utility of 4-(4-Bromophenoxy)phenol in designing small-molecule inhibitors targeting specific biological pathways. For instance, studies have demonstrated its potential as a precursor in synthesizing kinase inhibitors, which play a pivotal role in cancer therapy. The bromine atom on the aromatic ring can be selectively modified through cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, allowing for the introduction of diverse functional groups and tailoring the pharmacological properties of the resulting compounds.

In addition to its role in drug development, 4-(4-Bromophenoxy)phenol has been investigated for its applications in material science. Its ability to form stable complexes with metal ions has led to research into its use as a ligand in catalytic systems. These complexes can exhibit unique electronic properties, making them suitable for applications in organic synthesis and electronic materials. The interplay between the bromine and hydroxyl groups also contributes to its chelating capabilities, which are essential for designing efficient catalysts.

The synthesis of 4-(4-Bromophenoxy)phenol typically involves multi-step organic reactions starting from readily available aromatic precursors. A common synthetic route includes the bromination of 4-methoxyphenol followed by etherification to introduce the phenoxy group. Advanced techniques such as flow chemistry have been employed to optimize these reactions, improving yield and purity while reducing environmental impact. These methodologies align with the growing emphasis on sustainable chemical practices in industrial and academic settings.

From a medicinal chemistry perspective, the structural features of 4-(4-Bromophenoxy)phenol make it an attractive scaffold for further derivatization. Researchers have explored modifications at both the brominated ring and the phenoxy substituent to enhance bioavailability and target specificity. For example, replacing the bromine atom with other halogens or introducing heterocyclic moieties has led to compounds with improved pharmacokinetic profiles. Such modifications underscore the importance of structural diversity in drug discovery.

The computational modeling of 4-(4-Bromophenoxy)phenol has also advanced significantly, providing insights into its interactions with biological targets. Molecular docking studies have been instrumental in predicting binding affinities and identifying potential lead compounds for further optimization. These computational approaches complement experimental efforts, enabling faster screening of large libraries of derivatives and accelerating the drug development process.

In conclusion, 4-(4-Bromophenoxy)phenol (CAS No. 13320-48-4) represents a compound with broad applicability across multiple domains of chemistry and biology. Its unique structural attributes make it a valuable building block for synthesizing novel therapeutic agents and functional materials. As research continues to uncover new synthetic strategies and pharmacological applications, this compound is poised to remain at the forefront of chemical innovation.

• 2050-47-7(PBDE 15)
• 83694-71-7(1-Bromo-3-(4-bromophenoxy)benzene)
• 101-55-3(1-Bromo-4-phenoxybenzene)
• 6903-63-5(3,3'-Dibromodiphenyl Ether)
• 32220-74-9(Benzene, 1,3-bis(3-bromophenoxy)-)
• 23840-43-9(Benzene,1-(3-bromophenoxy)-3-phenoxy-)
• 152404-45-0(4-Bromoanisole-2,3,5,6-d4)
• 147217-79-6(1,3-Dibromo-5-(3-bromophenoxy)benzene)
• 54590-36-2(Benzene, 1-(4-bromophenoxy)-4-phenoxy-)
• 6876-00-2(1-Bromo-3-phenoxybenzene)